Annovis Bio, Inc.盘中异动急速下跌9.96%报6.56美元

自选股智能写手04-30

北京时间2024年04月30日21时32分，Annovis Bio, Inc.（ANVS.us）股票出现异动，股价急速下挫9.96%。截至发稿，该股报6.56美元/股，成交量13.0498万股，换手率1.18%，振幅6.87%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-56.20百万美元，每股收益-6.23美元，毛利0.00美元，市盈率-1.05倍。机构评级方面，在所有5家参与评级...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2431232303?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-04-30 21:32","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2431232303","market":"us","top_or_hot":-1,"title":"Annovis Bio, Inc.盘中异动 急速下跌9.96%报6.56美元","media":"自选股智能写手","content":"<div>\n<p>北京时间2024年04月30日21时32分，Annovis Bio, Inc.（ANVS.us）股票出现异动，股价急速下挫9.96%。截至发稿，该股报6.56美元/股，成交量13.0498万股，换手率1.18%，振幅6.87%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-56.20百万美元，每股收益-6.23美元，毛利0.00美元，市盈率-1.05倍。机构评级方面，在所有5家参与评级...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024043021323587c3f684&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Annovis Bio, Inc.盘中异动 急速下跌9.96%报6.56美元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAnnovis Bio, Inc.盘中异动 急速下跌9.96%报6.56美元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-04-30 21:32 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024043021323587c3f684&s=b><strong>自选股智能写手</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2024年04月30日21时32分，Annovis Bio, Inc.（ANVS.us）股票出现异动，股价急速下挫9.96%。截至发稿，该股报6.56美元/股，成交量13.0498万股，换手率1.18%，振幅6.87%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-56.20百万美元，每股收益-6.23美元，毛利0.00美元，市盈率-1.05倍。机构评级方面，在所有5家参与评级...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024043021323587c3f684&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"ANVS","symbol_name":"Annovis Bio, Inc.","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024043021323587c3f684&s=b","article_id":"2431232303","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024043021323587c3f684&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2431232303","pubTimestamp":1714483955,"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"北京时间2024年04月30日21时32分，Annovis Bio, Inc.股票出现异动，股价急速下挫9.96%。Annovis Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.09%。Annovis Bio, Inc.公司简介：Annovis Bio Inc是一家临床阶段的制药公司，专注于开发和商业化治疗帕金森氏症和阿尔茨海默氏病和其他神经退行性疾病的药物。该信息摘要如下：HC Wainwright & Co.：重申Annovis Bio评级，由买入调整至买入评级, 目标价30.00美元。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"ANVS":"Annovis Bio, Inc.","BK4139":"生物科技"},"translate_title":"Annovis Bio, Inc. fell 9.96% to $6.56","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ANVS":1},"content_text":"北京时间2024年04月30日21时32分，Annovis Bio, Inc.（ANVS.us）股票出现异动，股价急速下挫9.96%。截至发稿，该股报6.56美元/股，成交量13.0498万股，换手率1.18%，振幅6.87%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-56.20百万美元，每股收益-6.23美元，毛利0.00美元，市盈率-1.05倍。机构评级方面，在所有5家参与评级的机构中，80%的券商给予买入建议，20%的券商给予持有建议，无券商给予卖出建议。Annovis Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.09%。其相关个股中，Cyclacel Pharmaceuticals, Inc.、Biorestorative Therapies, Inc.、Nkgen Biotech Inc C/Wts 31/05/2028(To Pur Com)涨幅较大，Cyclacel Pharmaceuticals, Inc.、Biorestorative Therapies, Inc.、Zyversa Therapeutics, Inc.较为活跃，换手率分别为519.12%、164.96%、7.80%，振幅较大的相关个股有Ocean Biomedical Inc C/Wts 14/02/2028 (To Pur Com)、Cyclacel Pharmaceuticals, Inc.、Harmony Biosciences Holdings, Inc.，振幅分别为10.41%、8.82%、8.10%。Annovis Bio, Inc.公司简介：Annovis Bio Inc是一家临床阶段的制药公司，专注于开发和商业化治疗帕金森氏症和阿尔茨海默氏病和其他神经退行性疾病的药物。该公司管线产品有：Buntanetap 用于治疗慢性神经退行性疾病 - 包括 AD 和 PD； ANVS405治疗急性神经退行性疾病； 以及用于高级 AD 的 ANVS301。消息层面，截至21时32分，《HC Wainwright & Co.：重申Annovis Bio(ANVS.US)评级，由买入调整至买入评级, 目标价30.00美元。》资讯为影响Annovis Bio, Inc.的重要信息。该信息摘要如下：HC Wainwright & Co.：重申Annovis Bio(ANVS.US)评级，由买入调整至买入评级, 目标价30.00美元。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":null,"is_publish_news":null,"is_publish_highlight":null,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2431232303"}

Annovis Bio, Inc.盘中异动 急速下跌9.96%报6.56美元

精彩评论

Annovis Bio, Inc.盘中异动急速下跌9.96%报6.56美元